AWG ORIGIN® treatment refers to the treatment provided at facilities using AWG ORIGIN® devices; in Japan, the name of this treatment or service is also covered by a registered service mark held by an ASIAS group company. Here we set out, based on the facts, the development history and mechanism of the technology, and where ASIAS Corp. and its affiliates stand.
The developer of AWG (Arbitrary Waveform Generator) technology is Dr. Masayuki Matsuura. Its background includes US Patent 6,424,864 B1 and others, and it has developed as a device that acts on living tissue by combining multiple frequencies.
ASIAS Corp. is the authorized business that develops, manufactures, and sells devices carrying on this technology under the AWG ORIGIN® / QPA® brands (both registered trademarks). For the medical-device certification classes and details of authorized handling, please see the Products page.
In Japan, the name of the treatment or service using this technology is covered by a registered service mark held by an ASIAS group company (Registration No. 6320554 and others). On this English site, the treatment is described as AWG ORIGIN® treatment. The brand handled by ASIAS Corp. for the devices and products themselves is "AWG ORIGIN® / QPA®." Because the market also contains similar treatments using different devices or offered by other businesses, the word "AWG" on its own may not be enough to identify which device or which business a treatment uses.
The genuine devices that ASIAS Corp. develops and handles are clearly identified by the registered trademarks AWG ORIGIN® / QPA®. When considering adoption, we recommend confirming that a seller or facility is an authorized one.
The cells and tissues that make up the body are said to vibrate at their own characteristic frequencies, and AWG ORIGIN® is a low-frequency therapy device that acts on living tissue by selecting multiple frequencies. ASIAS presents this technical background in connection with research areas such as fascia (the body-wide connective-tissue network), bioelectricity, and EZ water (structured water).
The detailed theoretical background and research hypotheses are explained on the Technology page. These are explanations as research hypotheses and physical models; they do not guarantee the diagnosis, treatment, or cure of any specific disease.
AWG ORIGIN® (AC5000, AC5100, AC6000) is a low-frequency therapy device classified under category "Machinery and Instruments (12): Instruments for Physical Therapy" as a designated controlled medical device (Class II) and a medical device requiring specified maintenance management (medical device certification numbers: AC6000 303AGBZX00016000 / AC5000 and AC5100 230ADBZX00035000). Ordinary home-use low-frequency therapy devices are characterized under JIS T 2003 ("Household Electrotherapeutic Devices") by a base frequency of 1,200 Hz or below; US Patent 6,424,864 B1, the technical background of AWG ORIGIN®, describes a method that uses multiple frequencies selected from the 1 Hz to 10,000 Hz range, so it is a device with a different class and technical background from a home-use low-frequency therapy device. If you have a pre-existing condition (heart disease, pacemaker use, etc.), please consult your physician and use it in accordance with the precautions in the instruction manual.
When received as a treatment, it is self-pay care (not covered by insurance), and each facility sets its own fees. For specific costs, please contact the treatment provider or clinic you are considering directly.
Authorized facilities that use AWG ORIGIN® are listed on the Facilities page. If you are looking for genuine products, please check that page or contact ASIAS Corp. directly.
A 2018 review article, "Cancer pain treatment using an AWG treatment device," by Dr. Toru Fujita (Saranuma Clinic, Eitokukai Medical Corporation) is indexed with bibliographic information in J-GLOBAL. According to the J-GLOBAL record, it appeared in Monthly Medical Science Digest Vol. 44 No. 12, pages 683–684.
In the original paper materials that we keep, ASIAS Corp. is explicitly named as the device seller, and figures of the device in question are included. For this reason, we present it not merely as a document that happens to contain the same name, but as a document in which the relationship between ASIAS Corp. and this device can be confirmed from the original materials.
This article is the author's review and clinical description; ASIAS Corp. does not guarantee a treatment effect on any specific disease.
Treatment provided at facilities using AWG ORIGIN® devices — devices built on Arbitrary Waveform Generator technology — is referred to here as AWG ORIGIN® treatment. In Japan, the name of this treatment or service is also covered by a registered service mark held by an ASIAS group company (registered in the treatment-and-services classes, Class 41 and Class 44; Registration No. 6320554 and others), separate from the device brand AWG ORIGIN® / QPA®. The developer of the underlying technology is Dr. Masayuki Matsuura, and its background includes US Patent 6,424,864 B1 and others. ASIAS Corp. is the authorized seller that develops and handles the AWG ORIGIN® / QPA® devices. This explanation introduces the background and mechanism of the technology; it does not guarantee the diagnosis, treatment, or cure of any specific disease.
AWG ORIGIN® treatment refers to the treatment or service provided using AWG ORIGIN® devices; in Japan this treatment name is also covered by a registered service mark held by an ASIAS group company. "AWG ORIGIN® / QPA®" is the brand name (a registered trademark) for the devices and products that ASIAS Corp. develops and handles. The device brand and the treatment name are registered separately in their appropriate classes. We recommend checking directly with each treatment provider or seller about the origin of a device and who handles it.
The cells and tissues that make up the body are said to have their own characteristic frequencies, and AWG ORIGIN® is a device that acts on living tissue using multiple frequencies. ASIAS presents this technical background in connection with research areas such as fascia (the connective-tissue network), bioelectricity, and EZ water (structured water). For the detailed technical background, please see the Technology page. This is an explanation as a research hypothesis and a physical model; it does not guarantee any effect.
AWG ORIGIN® is a low-frequency therapy device classified as a designated controlled medical device (Class II) and a medical device requiring specified maintenance management. It is used with pads attached to the body. Unlike an ordinary home-use low-frequency therapy device (which JIS T 2003 characterizes as having a base frequency of 1,200 Hz or below), US Patent 6,424,864 B1, the technical background of AWG ORIGIN®, describes a method that uses multiple frequencies selected from the 1 Hz to 10,000 Hz range. Whether it can be used may differ depending on individual physical conditions (heart disease, pacemaker use, etc.), so if you have a pre-existing condition, please consult your physician and use it in accordance with the precautions in the instruction manual.
AWG ORIGIN® treatment is self-pay care (not covered by insurance), with each facility setting its own fees. Because costs differ by facility, please contact the treatment provider or clinic you are considering directly. ASIAS Corp. is the developer and seller of the device and is not involved in setting treatment fees.
Authorized facilities that use AWG ORIGIN® are listed on the Facilities page. Because some providers in the market use similar names, if you are looking for genuine products, please check that page or contact us directly.
* This page introduces the development history and technical background of AWG ORIGIN® / QPA®; it does not guarantee any treatment, diagnostic, or preventive effect for any specific disease. If you have concerns about your health or are under treatment at a medical institution, please consult your physician or medical institution.